drugset / Trial / NCT01192802

Efficacy of Albendazole to Treat Intestinal Helminths and Its Effect on Gut Microflora

NCT01192802

Phase 4 Completed 200 enrolled Albert Schweitzer Hospital
RandomizedSingle-groupSingle-blindTreatment

Summary

Albendazole is a main anti-helminth, however there is a lack of data regarding its efficacy in the school children population. The aim of this study is to evaluate the efficacy of the albendazole one versus two and three doses, in school children infected with intestinal helminth.

Timeline

Start
2010-08
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Albendazole Small molecule 400 mg